BOCA RATON, Fla. (Business Wire EON) June 30, 2008 -- University Health Industries Inc., (OTCBB:UVHI) a Florida corporation engaged in the development, marketing and sale of proprietary, patent-pending nutraceutical products, including its leading brands Arthroleve(TM) and Zenstral PMS(TM), announced today that it is launching a new pet health care division.

UHI's overall strategy has always included pet health care and we are excited about beginning the process of moving this forward. This new division complements the Company's current offerings in both its human health and environmental products.

The pet health care division is designed to expand University Health Industries' current market focus on human health into the pet health care market. The American Pet Product Manufactures Association (APPMA) estimates 2008 sales to be $10.3 billion for pet supplies and OTC medicines.

The lead product will be a pet formulated version of UHI's popular and successful Arthroleve™ product for joint health and arthritis, which will be designed with a dosage and delivery system specific to canines. Small animal veterinary analgesics has been one of the fastest growing segments of the pet health care market in the last ten years, since the launch of the non-steroidal anti-inflammatory drug (NSAID) Rimadyl® in 1996. Due to concerns over side effects associated with NSAIDS, many consumers choose to try nutraceutical products first. Currently, the canine joint health market is led primarily by glucosamine/chondroitin containing products including SynoviCare® and Cosequin®. UHI's adaptation of Artholeve™ for the canine market will allow us to offer consumers a unique patent-pending formulation with clinically-proven ingredients.

Dean Peloso, Chief Executive Officer of University Health Industries, was quoted as saying, “UHI's overall strategy has always included pet health care and we are excited about beginning the process of moving this forward. This new division complements the Company's current offerings in both its human health and environmental products.”

University Health Industries' mission is to deliver the latest advances and discoveries in natural compounds packaged in our unique patented formulations including Arthroleve™ (www.arthroleve.com) as well as Zenstral PMS™ (www.zenstralpms.com) and delivered to satisfy the needs of consumers for the promotion of health for many common age-related health concerns. www.universityhealthindustries.com.

Safe Harbor Forward-Looking Statements:

Except for historical matters contained herein, the matters discussed in this press release are “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that these forward-looking statements reflect numerous assumptions and involve risks and uncertainties that may affect University Health Industries, Inc. and its subsidiary businesses (collectively, the “Company”) and prospects and cause actual results to differ materially from these forward-looking statements.

Keyword Tags: arthroleve, arthroleve.com, arthroleve testimonial, pet arthritis, pet health, pet health care, pets, university health industries

Post Comment:
Trackback URL: http://eon.businesswire.com/pingpr.php/SW5zZS1JbnNlLUZhbHUtUGlnZy1FbXB0LVNpbmctWmVybw==

university health industries pets pet health care pet arthritis arthroleve.com arthroleve testimonial arthroleve

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web